Stock PSTX POSEIDA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Poseida Therapeutics, Inc.

Equities

PSTX

US73730P1084

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
2.99 USD +3.10% Intraday chart for Poseida Therapeutics, Inc. +0.67% -11.01%
May. 14 Poseida Therapeutics Q1 Net Loss Narrows, Revenue Rises MT
May. 14 Earnings Flash (PSTX) POSEIDA THERAPEUTICS Reports Q1 Revenue $28.1M MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Poseida Highlights Strong Progress on Its Genetic Medicine Programs at the American Society for Gene and Cell Therapy 27th Annual Meeting
AQ
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
PR
Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
PR
Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
AQ
Poseida Therapeutics Hosts Gene Therapy R&D Day Highlighting New Scientific Advancements and Pipeline Focus
PR
Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PR
Poseida Therapeutics to Present at H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
PR
Poseida Therapeutics : Provides Updates and Financial Results for the Fourth Quarter and Full Year 2023 - Form 8-K
PU
Poseida Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PR
Poseida Therapeutics to Present at Two Upcoming Investor Conferences
PR
Poseida Therapeutics to Present at the 65th ASH Annual Meeting and Exposition
AQ
Poseida Therapeutics Announces Leadership Transition
PR
Poseida Therapeutics to Present at Two Upcoming Investor Conferences
PR
Poseida Therapeutics Announces Strategic Investment by Astellas and Provides Business Update
AQ
Poseida Therapeutics to Join Russell 3000 and Russell 2000 Indexes
AQ
Poseida Therapeutics to Join Russell 3000® and Russell 2000® Indexes
PR
POSEIDA THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
POSEIDA THERAPEUTICS, INC. : Termination of a Material Definitive Agreement, Other Events (form 8-K)
AQ
Poseida Therapeutics Announces Virtual 2023 Annual Meeting of Stockholders
PR
Poseida Therapeutics to Present at Stifel 2023 Tailoring Genes, Genetic Medicines Day
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PSTX Stock
  4. News Poseida Therapeutics, Inc.
  5. Press Releases